Biotech voluntarily disclosed the announcement that BAT6005 and BAT1308 injections obtained approval letters for drug clinical trials

SZSI · May 25

The translation is provided by third-party software.

The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.